Earth Life Sciences (CLTS) Ratios
Earth Life Sciences Ratios
CLTS's free cash flow for Q3 2022 was $800.00M. For the 2022 fiscal year, CLTS's free cash flow was increased by $0.00 and operating cash flow was $800.00M. See a summary of the company’s cash flow.
| Ratios | Dec 21 | Dec 20 | Dec 19 | Dec 18 | Dec 17 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quick Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Solvency Ratio | -0.06 | -4.82 | -0.16 | -1.54 | -21.97 |
| Operating Cash Flow Ratio | -0.04 | -0.12 | -0.00 | 0.00 | 0.00 |
| Short-Term Operating Cash Flow Coverage | -0.05 | -0.14 | -0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ -372.21K | $ -377.91K | $ -337.78K | $ -284.50K | $ -308.93K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.07 | 1.85 | 0.00 | 66.78 | 33.39 |
| Debt-to-Equity Ratio | 0.07 | -1.62 | -0.10 | -0.12 | -0.11 |
| Debt-to-Capital Ratio | 0.07 | 2.62 | -0.11 | -0.13 | -0.12 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.09 | -0.87 | 0.00 | -0.00 | -0.00 |
| Debt Service Coverage Ratio | 0.00 | -5.58 | -0.19 | -13.39 | -207.47 |
| Interest Coverage Ratio | -72.60 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.09 | 0.06 | 0.12 | 0.01 | 0.01 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 0.00 | -0.18 | -0.61 | -0.07 | -0.00 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 101.34% | 99.67% | 100.00% | 100.00% | 17470.06% |
| Return on Assets (ROA) | -35.78% | -1035.23% | 0.00% | -89387.76% | -692741.33% |
| Return on Equity (ROE) | -39.07% | 902.39% | 15.92% | 154.22% | 2204.53% |
| Return on Capital Employed (ROCE) | -38.56% | 905.36% | 15.92% | 154.22% | 12.62% |
| Return on Invested Capital (ROIC) | -35.95% | -1470.66% | 94.41% | 174.30% | 14.12% |
| Return on Tangible Assets | -264000.00% | 0.00% | 0.00% | -89387.76% | -692741.33% |
| Earnings Yield | -50.04% | -33.24% | -2.24% | -14.62% | -108.99% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | -42430.13 | -187547.43 | -205749.01 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 42430.13 | 187547.43 | 205749.01 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | -0.00 | -0.00 | 0.00 | 0.00 |
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | 0.00 | 0.00 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | -0.05 | -0.14 | -0.00 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -0.50% | -0.83% | -0.00% | 0.00% | 0.00% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -2.00 | -3.01 | -44.58 | -6.84 | -0.92 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 0.78 | -27.15 | -7.10 | -10.55 | -20.23 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -199.50 | -120.77 | -69845.34 | 0.00 | 0.00 |
| Price-to-Operating Cash Flow Ratio | -199.50 | -120.77 | -69845.34 | 0.00 | 0.00 |
| Price-to-Earnings Growth (PEG) Ratio | 0.08 | -0.00 | 0.53 | 0.07 | -0.00 |
| Enterprise Value Multiple | 0.00 | -3.19 | -45.61 | -6.92 | -0.92 |
| Enterprise Value | 3.46M | 5.81M | 2.43M | 3.03M | 6.26M |
| EV to EBITDA | 0.00 | -3.19 | -45.61 | -6.92 | -0.92 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -218.04 | -127.96 | -70798.56 | 0.00 | 0.00 |
| EV to Operating Cash Flow | -218.04 | -127.96 | -70798.56 | 0.00 | 0.00 |
| Tangible Book Value Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Shareholders’ Equity Per Share | 0.01 | -0.00 | -0.00 | -0.00 | -0.00 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.03 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.01 | 1.00 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.01 | 0.02 | 0.00 | 0.00 | 0.00 |
Currency in USD